SCHEMBL12779148

SCHEMBL12779148

CNCCCC(N)C(N)=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KISS1R Q969F8 1/20 0.44
DPP7 Q9UHL4 2/20 0.40
DDAH1 O94760 3/20 0.37
NOS2 P35228 5/20 0.36
NOS1 P29475 4/20 0.36
NOS3 P29474 3/20 0.36
CYP2C19 P33261 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
SLC15A1 P46059 1/20 0.36
OTC P00480 1/20 0.36
HTR2A P28223 1/20 0.35
HRH1 P35367 1/20 0.35
ANPEP P15144 2/20 0.35
RNPEP Q9H4A4 2/20 0.35
CYP1A2 P05177 2/20 0.35
TSHR P16473 2/20 0.35
DNPEP Q9ULA0 1/20 0.35
CYP3A4 P08684 1/20 0.35
GNAI3 P08754 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16421611 1.00 KISS1R (0.44) KISS1RDPP7DDAH1NOS2NOS1
Hydrochloric Acid SCHEMBL28656623 0.98 KISS1R (0.43) KISS1RDPP7DDAH1NOS2NOS1
Hydrochloric Acid SCHEMBL28656624 0.98 KISS1R (0.43) KISS1RDPP7DDAH1NOS2NOS1
SCHEMBL22769065 0.94 DPP7 (0.43) KISS1RDPP7DDAH1NOS2NOS1
SCHEMBL20653680 0.94 DPP7 (0.43) KISS1RDPP7DDAH1NOS2NOS1
SCHEMBL13456304 0.94 DPP7 (0.43) KISS1RDPP7DDAH1NOS2NOS1
SCHEMBL14288769 0.86
SCHEMBL10045772 0.83 GSR (0.54) DDAH1NOS2NOS1NOS3CYP2C19
SCHEMBL31688818 0.83 GSR (0.54) DDAH1NOS2NOS1NOS3CYP2C19
SCHEMBL13776588 0.83 KISS1R (0.53) KISS1RDPP7NOS2NOS1NOS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011048029-A1 CYCLIC PEPTIDE SYNTHESIS GE HEALTHCARE AS (NO) 2011-04-28 WO disclosed
EP-1884520-A2 Daptomycin analogs as antibacterial agents Cubist Pharmaceuticals, Inc. (US) 2008-02-06 EP disclosed